Your browser doesn't support javascript.
loading
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease.
Chen, Chaobo; Wu, Hanghang; Ye, Hui; Tortajada, Agustín; Rodríguez-Perales, Sandra; Torres-Ruiz, Raúl; Vidal, August; Peligros, Maria Isabel; Reissing, Johanna; Bruns, Tony; Mohamed, Mohamed Ramadan; Zheng, Kang; Lujambio, Amaia; Iraburu, Maria J; Colyn, Leticia; Latasa, Maria Ujue; Arechederra, María; Fernández-Barrena, Maite G; Berasain, Carmen; Vaquero, Javier; Bañares, Rafael; Nelson, Leonard J; Trautwein, Christian; Davis, Roger J; Martinez-Naves, Eduardo; Nevzorova, Yulia A; Villanueva, Alberto; Avila, Matias A; Cubero, Francisco Javier.
Afiliação
  • Chen C; Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, 28040 Madrid, Spain.
  • Wu H; 12 de Octubre Health Research Institute (imas12), 28041 Madrid, Spain.
  • Ye H; Department of General Surgery, Wuxi Branch of Zhongda Hospital, Southeast University, Wuxi 214105, China.
  • Tortajada A; Department of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China.
  • Rodríguez-Perales S; Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, 28040 Madrid, Spain.
  • Torres-Ruiz R; Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, 28040 Madrid, Spain.
  • Vidal A; Department of Anesthesia, Zhongda Hospital, Southeast University, Nanjing 210008, China.
  • Peligros MI; Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, 28040 Madrid, Spain.
  • Reissing J; 12 de Octubre Health Research Institute (imas12), 28041 Madrid, Spain.
  • Bruns T; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.
  • Mohamed MR; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.
  • Zheng K; Laboratorio de Investigación Traslacional (LRT1)-ProCURE, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Lujambio A; Institute of Pathology, Hospital Universitario Gregorio Marañon, 28007 Madrid, Spain.
  • Iraburu MJ; Department of Internal Medicine III, University Hospital RWTH, 52074 Aachen, Germany.
  • Colyn L; Department of Internal Medicine III, University Hospital RWTH, 52074 Aachen, Germany.
  • Latasa MU; Department of Internal Medicine III, University Hospital RWTH, 52074 Aachen, Germany.
  • Arechederra M; Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, 28040 Madrid, Spain.
  • Fernández-Barrena MG; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Berasain C; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Vaquero J; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Bañares R; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Nelson LJ; Department of Biochemistry and Genetics, University of Navarra, 31008 Pamplona, Spain.
  • Trautwein C; Hepatology Program, Cima, University of Navarra, 31008 Pamplona, Spain.
  • Davis RJ; Hepatology Program, Cima, University of Navarra, 31008 Pamplona, Spain.
  • Martinez-Naves E; Hepatology Program, Cima, University of Navarra, 31008 Pamplona, Spain.
  • Nevzorova YA; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Villanueva A; Instituto de Investigaciones Sanitarias de Navarra-IdiSNA, 31008 Pamplona, Spain.
  • Avila MA; Hepatology Program, Cima, University of Navarra, 31008 Pamplona, Spain.
  • Cubero FJ; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Cancers (Basel) ; 14(1)2021 Dec 24.
Article em En | MEDLINE | ID: mdl-35008241
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha